Clinical Trials Browser

Phase 2 × Uterine Neoplasms × Bevacizumab × Clear all

NCT00626561 2014-07-07

Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix

Phase 2 Terminated

4 enrolled 2 charts

Uterine Cervical Neoplasms, Uterine Neoplasms